Related Experiment Video
Updated: Aug 9, 2026

Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy
Published on: June 8, 2018
Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1
Iha Park1, Hava Karsenty Avraham
1Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, 4 Blackfan Circle, 3rd Floor, Boston, MA 02115, USA.
Abstract:
Topoisomerase II is essential for cell proliferation and survival and has been a target of various anticancer drugs. ICRF-193 has long been used as a catalytic inhibitor to study the function of topoisomerase II. Here, we show that ICRF-193 treatment induces DNA damage signaling. Treatment with ICRF-193 induced G2 arrest and DNA damage signaling involving gamma-H2AX foci formation and CHK2 phosphorylation. DNA damage by ICRF-193 was further demonstrated by formation of the nuclear foci of 53BP1, NBS1, BRCA1, MDC1, and FANCD2 and increased comet tail moment. The DNA damage signaling induced by ICRF-193 was mediated by ATM and ATR and was restricted to cells in specific cell cycle stages such as S, G2, and mitosis including late and early G1 phases. Downstream signaling of ATM and ATR involved the phosphorylation of CHK2 and BRCA1. Altogether, our results demonstrate that ICRF-193 induces DNA damage signaling in a cell cycle-dependent manner and suggest that topoisomerase II might be essential for the progression of the cell cycle at several stages including DNA decondensation.
Insights
ICRF-193, a topoisomerase II inhibitor, triggers DNA damage signaling and cell cycle arrest. This DNA damage response is cell cycle-dependent, highlighting topoisomerase II
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Topoisomerase II is crucial for cell proliferation and survival.
- It is a validated target for anticancer drug development.
- ICRF-193 is a known catalytic inhibitor used to study topoisomerase II function.
Purpose of the Study:
- To investigate the effects of ICRF-193 on DNA damage signaling.
- To determine the cell cycle dependency of ICRF-193-induced DNA damage.
- To elucidate the signaling pathways involved in the response to ICRF-193.
Main Methods:
- Treatment of cells with ICRF-193.
- Analysis of DNA damage markers (gamma-H2AX, 53BP1, NBS1, BRCA1, MDC1, FANCD2 foci, comet assay).
- Cell cycle analysis and assessment of signaling pathway activation (ATM, ATR, CHK2, BRCA1 phosphorylation).
Main Results:
- ICRF-193 treatment induced G2 arrest and significant DNA damage signaling.
- Formation of multiple DNA damage foci (gamma-H2AX, 53BP1, NBS1, BRCA1, MDC1, FANCD2) and increased comet tail moment confirmed DNA damage.
- ATM and ATR mediated the DNA damage signaling, which was cell cycle-dependent (S, G2, M, early/late G1 phases).
Conclusions:
- ICRF-193 induces DNA damage signaling in a cell cycle-dependent manner.
- Topoisomerase II activity is essential for cell cycle progression, including DNA decondensation.
- These findings provide insights into the mechanism of action of topoisomerase II inhibitors.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Negative Regulator Molecules

